Evidence map›Paper›PMID 33202938›Full record

ArticleMetabolites2020

Divergent Impact of Glucose Availability on Human Virus-Specific and Generically Activated CD8 T Cells.

Jenifer Sanchez, Ian Jackson, Katie R Flaherty, Tamara Muliaditan, Anna Schurich

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Jenifer SanchezDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, King's College London, London SE1 9RT, UK.ORCID 0000-0001-7417-9259
Ian JacksonPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, Guy's Hospital, King's College London, London SE1 9RT, UK.
Katie R FlahertyDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, King's College London, London SE1 9RT, UK.
Tamara MuliaditanLeucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Anna SchurichDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, King's College London, London SE1 9RT, UK.ORCID 0000-0001-5263-6674
Guy's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon activation T cells engage glucose metabolism to fuel the costly effector functions needed for a robust immune response. Consequently, the availability of glucose can impact on T cell function. The glucose concentrations used in conventional culture media and common metabolic assays are often artificially high, representing hyperglycaemic levels rarely present in vivo. We show here that reducing glucose concentration to physiological levels in culture differentially impacted on virus-specific compared to generically activated human CD8 T cell responses. In virus-specific T cells, limiting glucose availability significantly reduced the frequency of effector-cytokine producing T cells, but promoted the upregulation of CD69 and CD103 associated with an increased capacity for tissue retention. In contrast the functionality of generically activated T cells was largely unaffected and these showed reduced differentiation towards a residency phenotype. Furthermore, T cells being cultured at physiological glucose concentrations were more susceptible to viral infection. This setting resulted in significantly improved lentiviral transduction rates of primary cells. Our data suggest that CD8 T cells are exquisitely adapted to their niche and provide a reminder of the need to better mimic physiological conditions to study the complex nature of the human CD8 T cell immune response.

Indexed as

culture conditionEBVglucose metabolisminfluenzavirus-specific CD8 T cell

Identifiers

PMID33202938
PMCPMC7696163
OpenAlexW3101959840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.